A Point Biopharma Global cancer therapy key to a $1.4 billion Eli Lilly M&A deal has met the main goal of its pivotal clinical trial in prostate cancer. But the results raise questions about how well ...
Biff America’s column on the prostate gland had good advice. Men older than 40 need to start developing an information base in order to detect prostate cancer. The digital rectal exam, which had been ...
NORTH BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., a global leader ...
Secret Life of Mom on MSN
Easier way to treat prostate cancer could become new 'standard of care,' doctors say
Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results